{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:04:32Z","timestamp":1762866272167},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Behcet's disease (BD) is a systemic inflammatory disease with the histopathological features of leukocytoclastic vasculitis that affects nearly all organs and systems. When it involves the intestine, it is called entero-Behcet's disease (entero-BD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>Here we described a 23-year-old man with entero-BD refractory to conventional therapies who responded well to the combination therapy of infliximab, an anti-tumor-necrosis-factor (TNF)-alpha antibody, and thalidomide. After combination treatment, the patient\u2019s symptoms improved greatly and his Crohn's Disease Activity Index (CDAI) score decreased from 344 to 52 points, accompanied by a body weight increase from 53\u00a0kg to 64\u00a0kg. A follow-up endoscopy performed 10\u00a0weeks after the treatment showed significant improvement and the patient's multiple ulcers had healed well.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The combination therapy of infliximab and thalidomide appears to be clinically effective in a patient with refractory entero-BD. However, further studies need to be performed to evaluate the efficacy of this combination therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-13-167","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T10:05:09Z","timestamp":1386583509000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Side","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,9]]},"reference":[{"issue":"12","key":"1028_CR1","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1136\/bjo.2007.124875","volume":"91","author":"H Keino","year":"2007","unstructured":"Keino H, Okada AA: Behcet's Disease: global epidemiology of an old silk road disease. Br J Ophthalmol. 2007, 91 (12): 1573-1574. 10.1136\/bjo.2007.124875.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1028_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2209\/tdcpublication.42.169","volume":"42","author":"T Hisamatsu","year":"2001","unstructured":"Hisamatsu T, Kishikawa H, Fukuya H, Matsuoka K, Mizuno Y, Nishida J: Combination therapy including pentoxifylline for entero-Behcet's disease. Bull Tokyo Dent Coll. 2001, 42 (3): 169-176. 10.2209\/tdcpublication.42.169.","journal-title":"Bull Tokyo Dent Coll"},{"issue":"9","key":"1028_CR3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/ibd.20457","volume":"14","author":"M Naganuma","year":"2008","unstructured":"Naganuma M, Sakuraba A, Hisamatsu T, Ochiai H, Hasegawa H, Ogata H, Iwao Y, Hibi T: Efficacy of infliximab for induction and maintenance of remission in intestinal Behcet's disease. Inflamm Bowel Dis. 2008, 14 (9): 1259-1264. 10.1002\/ibd.20457.","journal-title":"Inflamm Bowel Dis"},{"issue":"17","key":"1028_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med. 1999, 341 (17): 1284-1291. 10.1056\/NEJM199910213411707.","journal-title":"N Engl J Med"},{"issue":"6","key":"1028_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2165\/00063030-200013060-00004","volume":"13","author":"S Kitauchi","year":"2000","unstructured":"Kitauchi S, Nishi S, Nishioka S: Intestinal Behcet's disease: epidemiology, pathophysiology and potential of mesalazine. BioDrugs. 2000, 13 (6): 409-413. 10.2165\/00063030-200013060-00004.","journal-title":"BioDrugs"},{"issue":"1","key":"1028_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","volume":"53","author":"SB Cho","year":"2012","unstructured":"Cho SB, Cho S, Bang D: New insights in the clinical understanding of Behcet's disease. Yonsei Med J. 2012, 53 (1): 35-42. 10.3349\/ymj.2012.53.1.35.","journal-title":"Yonsei Med J"},{"issue":"4","key":"1028_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1053\/gast.2001.22556","volume":"120","author":"PV Hassard","year":"2001","unstructured":"Hassard PV, Binder SW, Nelson V, Vasiliauskas EA: Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: a case report. Gastroenterology. 2001, 120 (4): 995-999. 10.1053\/gast.2001.22556.","journal-title":"Gastroenterology"},{"issue":"4 Suppl 60","key":"1028_CR8","first-page":"S27","volume":"28","author":"A Ferrante","year":"2010","unstructured":"Ferrante A, Ciccia F, Principato A, Giardina AR, Impastato R, Peralta S, Triolo G: A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behcet's disease. Clin Exp Rheumatol. 2010, 28 (4 Suppl 60): S27-S30.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1028_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/01.meg.0000108345.41221.c2","volume":"16","author":"I Kirman","year":"2004","unstructured":"Kirman I, Whelan RL, Nielsen OH: Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004, 16 (7): 639-641. 10.1097\/01.meg.0000108345.41221.c2.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4 Suppl 60","key":"1028_CR10","first-page":"S102","volume":"28","author":"P Leccese","year":"2010","unstructured":"Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I: Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab. Clin Exp Rheumatol. 2010, 28 (4 Suppl 60): S102-","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1028_CR11","first-page":"774","volume":"109","author":"Y Shimizu","year":"2012","unstructured":"Shimizu Y, Takeda T, Matsumoto R, Yoshida K, Nakajima J, Atarashi T, Yanagisawa H, Kikuchi K, Kikuchi H: Clinical efficacy of adalimumab for a postoperative marginal ulcer in gastrointestinal Behcet disease. Nippon Shokakibyo Gakkai Zasshi. 2012, 109 (5): 774-780.","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"issue":"3","key":"1028_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G: Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med. 1991, 173 (3): 699-703. 10.1084\/jem.173.3.699.","journal-title":"J Exp Med"},{"issue":"6","key":"1028_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9343(99)00408-8","volume":"108","author":"L Calabrese","year":"2000","unstructured":"Calabrese L, Fleischer AB: Thalidomide: current and potential clinical applications. Am J Med. 2000, 108 (6): 487-495. 10.1016\/S0002-9343(99)00408-8.","journal-title":"Am J Med"},{"issue":"6","key":"1028_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H: Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998, 128 (6): 443-450. 10.7326\/0003-4819-128-6-199803150-00004.","journal-title":"Ann Intern Med"},{"issue":"6 Pt 1","key":"1028_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1542\/peds.103.6.1295","volume":"103","author":"LP Shek","year":"1999","unstructured":"Shek LP, Lee YS, Lee BW, Lehman TJ: Thalidomide responsiveness in an infant with Behcet's syndrome. Pediatrics. 1999, 103 (6 Pt 1): 1295-1297.","journal-title":"Pediatrics"},{"issue":"8","key":"1028_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/rheumatology\/40.8.933","volume":"40","author":"JA Kari","year":"2001","unstructured":"Kari JA, Shah V, Dillon MJ: Behcet's disease in UK children: clinical features and treatment including thalidomide. Rheumatology (Oxford). 2001, 40 (8): 933-938. 10.1093\/rheumatology\/40.8.933.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1028_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ibd.20317","volume":"14","author":"K Yasui","year":"2008","unstructured":"Yasui K, Uchida N, Akazawa Y, Nakamura S, Minami I, Amano Y, Yamazaki T: Thalidomide for treatment of intestinal involvement of juvenile-onset Behcet disease. Inflamm Bowel Dis. 2008, 14 (3): 396-400. 10.1002\/ibd.20317.","journal-title":"Inflamm Bowel Dis"},{"issue":"8697","key":"1028_CR18","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Behcet's disease","year":"1990","unstructured":"Criteria for diagnosis of Behcet's disease: International study group for Behcet's disease. Lancet. 1990, 335 (8697): 1078-1080.","journal-title":"Lancet"},{"issue":"2","key":"1028_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrrheum.2012.156","volume":"9","author":"NL Ambrose","year":"2013","unstructured":"Ambrose NL, Haskard DO: Differential diagnosis and management of Behcet syndrome. Nat Rev Rheumatol. 2013, 9 (2): 79-89.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"1028_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M Pineton De Chambrun","year":"2012","unstructured":"Pineton De Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D: New insights into the pathogenesis of Behcet's disease. Autoimmun Rev. 2012, 11 (10): 687-698. 10.1016\/j.autrev.2011.11.026.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1028_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","volume":"41","author":"A Arida","year":"2011","unstructured":"Arida A, Fragiadaki K, Giavri E, Sfikakis PP: Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011, 41 (1): 61-70. 10.1016\/j.semarthrit.2010.09.002.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"1028_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/rheumatology\/kep126","volume":"48","author":"S Iwata","year":"2009","unstructured":"Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y: Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease. Rheumatology (Oxford). 2009, 48 (8): 1012-1013. 10.1093\/rheumatology\/kep126.","journal-title":"Rheumatology (Oxford)"},{"issue":"4\u20135","key":"1028_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/08820538.2011.588665","volume":"26","author":"NR Benitah","year":"2011","unstructured":"Benitah NR, Sobrin L, Papaliodis GN: The use of biologic agents in the treatment of ocular manifestations of Behcet's disease. Semin Ophthalmol. 2011, 26 (4\u20135): 295-303.","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"1028_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/gut.49.5.725","volume":"49","author":"SP Travis","year":"2001","unstructured":"Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL: Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut. 2001, 49 (5): 725-728. 10.1136\/gut.49.5.725.","journal-title":"Gut"},{"issue":"1","key":"1028_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10350-004-6506-4","volume":"46","author":"MT Kram","year":"2003","unstructured":"Kram MT, May LD, Goodman S, Molinas S: Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum. 2003, 46 (1): 118-121. 10.1007\/s10350-004-6506-4.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"1028_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10067-006-0410-3","volume":"26","author":"JH Ju","year":"2007","unstructured":"Ju JH, Kwok SK, Seo SH, Yoon CH, Kim HY, Park SH: Successful treatment of life-threatening intestinal ulcer in Behcet's disease with infliximab: rapid healing of Behcet's ulcer with infliximab. Clin Rheumatol. 2007, 26 (8): 1383-1385. 10.1007\/s10067-006-0410-3.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1028_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3904\/kjim.2007.22.1.24","volume":"22","author":"JH Lee","year":"2007","unstructured":"Lee JH, Kim TN, Choi ST, Jang BI, Shin KC, Lee SB, Shim YR: Remission of intestinal Behcet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab). Korean J Intern Med. 2007, 22 (1): 24-27. 10.3904\/kjim.2007.22.1.24.","journal-title":"Korean J Intern Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-13-167\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:03:55Z","timestamp":1630551835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-13-167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-13-167","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"20 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"167"}}